Associated autoimmune diseases in children and adolescents with type 1 diabetes mellitus (T1DM)

Autoimmunity Reviews

Volumn 14, Issue 9, 2015, Pages 781-797

  Kakleas, Kostas ^a   Soldatou, Alexandra ^a   Karachaliou, Feneli ^b   Karavanaki, Kyriaki ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

Author keywords

Associated autoimmune diseases; Children; Polyglandular autoimmune syndromes; T1DM

Indexed keywords

GLUTEN;

ADOLESCENT; AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; CELIAC DISEASE; CHILD; DIABETES CONTROL; ENVIRONMENTAL FACTOR; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NEUROLOGIC DISEASE; PATHOGENESIS; PREVALENCE; REVIEW; SCREENING; THYROID CANCER; VITILIGO; AUTOIMMUNE DISEASES; COMPLICATION; IMMUNOLOGY; THYROID DISEASE;

ADOLESCENT; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CHILD; DIABETES MELLITUS, TYPE 1; HUMANS; PREVALENCE; THYROID DISEASES;

EID: 84938213351     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2015.05.002     Document Type: Review

References (381)

1. Castano L., Eisenbarth G.S. Type 1 diabetes: a chronic autoimmune disease of human, mouse and rat. Annu Rev Immunol 1990, 8:647-679.
2. Atkinson M.A., Maclaren N.K. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994, 331(21):1.
3. Atkinson M.A., Eisenbarth G.S. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001, 358(9277):221-229.
4. Krolewski A.S., Warram J.H., Rand L.I., Kahn C.R. Epidemiologic approach to the etiology of type 1 diabetes mellitus and its complications. N Engl J Med 1987, 317(22):1390-1399.
5. Cutolo M. Autoimmune polyendocrine syndromes. Autoimmun Rev Feb 2014, 13(2):85-89.
6. Michels A.W., Gottlieb P.A. Autoimmune polyglandular syndromes. Nat Rev Endocrinol 2010, 6(5):270-277.
7. Ben-Skowronek I., Michalczyk A., Piekarski R., Wysocka-Łukasik B., Banecka B. Type III Polyglandular Autoimmune Syndromes in children with type 1 diabetes mellitus. Ann Agric Environ Med 2013, 20(1):140-146.
8. Van den Driessche A., Eenkhoorn V., Van Gaal L., De Block C. Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review. Neth J Med Dec 2009, 67(11):376-387.
9. Winter W.E., Schatz D.A. Autoimmune markers in diabetes. Clin Chem 2011, 57:168-175.
10. Rowe P.A., Campbell-Thompson M.L., Schatz D.A., Atkinson M.A. The pancreas in human type 1 diabetes. Sem Immunopathol 2011, 33:29-43.
11. Oikarinen M., Tauriainen S., Honkanen T., Oikarinen S., Vuori K., Kaukinen K., et al. Detection of enteroviruses in the intestine of type 1 diabetes patients. Clin Exp Immunol 2007, 151:71-75.
12. Knip M., Virtanen S.M., Seppa K., Ilonen J., Savilathi E., Vaarala O., et al. Dietary intervention in infancy and later signs of beta-cell autoimmunity. N Engl J Med 2010, 363:1900-1908.
13. Forlenza G.P., Rewers M. The epidemic of type 1 diabetes: what is it telling us?. Curr Opin Endocrinol Diabetes Obes 2011, 18:248-251.
14. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009, 32(Suppl. 1):S62-S67.
15. Abiru N., Kawasaki E., Eguch K. Current knowledge of Japanese type 1 diabetic syndrome. Diabetes Metab Res Rev 2002, 18:357-366.
16. Kobayashi T., Nishida Y., Tanaka S., Aida K. Pathological changes in the pancreas of fulminant type 1 diabetes and slowly progressive insulin-dependent diabetes mellitus (SPIDDM): innate immunity in fulminant type 1 diabetes and SPIDDM. Diabetes Metab Res Rev 2011, 27:965-970.
17. Imagawa A., Hanafusa T. Fulminant type 1 diabetes-an important subtype in East Asia. Diabetes Metab Res Rev 2011, 27:959-964.
18. Shibasaki S., Imagawa A., Hanafusa T. Fulminant type 1 diabetes mellitus: a new class of type 1 diabetes. Adv Exp Med Biol 2012, 771:20-23.
19. Redondo M.J. LADA: time for a new definition. Diabetes 2013, 62:339-340.
20. Zampetti S., Capizzi M., Spoletini M., Campagna G., Leto GCipolloni L., et al. GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6). J Clin Endocrinol Metab 2012, 97:3759-3765.
21. Lohman T., Kellner K., Verlohren H.J., Krug J., Syeindorf J., Scherbaum W.A., et al. Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA). Diabetologia 2001, 44:1005-1010.
22. Fourlanos S., Dotta F., Greenbaum C.J., Palmer J.P., Ronandsson O., Colman P.G., et al. Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 2005, 48:2206-2212.
23. Pozzilli P., Buzzetti R. A new expression of diabetes: double diabetes. Trends Endocrinol Metab 2007, 18:52-57.
24. Ashcroft F.M., Rorsman P. Diabetes mellitus and the beta cell: the last ten years. Cell 2012, 148:1160-1171.
25. Velloso L.A., Eizirik D.L., Cnop M. Type 2 diabetes mellitus-an autoimmune disease?. Nat Rev Endocrinol 2013, 9(12):750-755.
26. Awdeh Z.L., Yunis E.J., Audeh M.J., Fici D., Pugliese A., Larsen C.E., et al. A genetic explanation for the rising incidence of type 1 diabetes, a polygenic disease. J Autoimmun 2006, 27:174-181.
27. Borchers A.T., Uibo R., Gershwin M.E. The geoepidemiology of type 1 diabetes. Autoimmun Rev 2010, 9:355-365.
28. Bach J.F. Infections and autoimmune diseases. J Autoimmun 2005, 25:74-80. [Suppl.].
29. Cohen I.R., Young D.B. Autoimmunity, microbial immunity and the immunological homunculus. Immunol Today 1991, 12:105-110.
30. Poletaev A.B., Stepanyuk V.L., Gershwin M.E. Integrating immunity: the immunculus and self-reactivity. J Autoimmun 2008, 30:68-73.
31. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor a-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995, 155:1151-1164.
32. Stanley H.M., Norris J.M., Barriga K., Hoffman M., Yu L., Miao D., et al. Is presence of islet autoantibodies at birth associated with development of persistent islet autoimmunity?. Diabetes Care 2004, 27:497-502.
33. Pearl-Yafe M., Iskovich S., Kaminitz A., Stein J., Yaniv I., Askenasy N. Does physiological beta cell turnover initiate autoimmune diabetes in the regional lymph nodes?. Autoimmun Rev 2006, 5:338-343.
34. D'Alise A.M., Auyeung V., Feuerer M., Nishio J., Fontenot J., Benoist C., et al. The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proc Natl Acad Sci U S A 2008, 105:19857-19862.
35. Yarkoni S., Kaminitz A., Sagiv Y., Askenasy N. Targeting of IL-2 receptor with a caspase fusion protein disrupts autoimmunity in prediabetic and diabetic NOD mice. Diabetologia 2010, 53:356-368.
36. Yolcu E.S., Ash S., Kaminitz A., Sagiv Y., Askenasy N., Yarkoni S. Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression. Immunol Cell Biol 2008, 86:650-658.
37. Bottazzo G.F., Floriu-Christensen A., Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiency. Lancet 1974, 2(7892):1279-1283.
38. Bottazzo G.F., Dean B.M., Gorsuch A.N., Cudworth A.G., Doniach D. Complement-fixing islet-cell antibodies in type 1 diabetes mellitus: possible monitors of active beta cell damage. Lancet 1980, 1(8170):668-672.
39. Johnson C., Millward M., Hoskins P., Bottazzo G.F., Pyke D.A. Islet cell antibodies as predictors of the later development of type 1 (insulin dependent) diabetes mellitus: a study in identical twins. Diabetologia 1989, 32(6):382-386.
40. Bingley P.J., Bonifacio S., Shattock M., Gilmor H.A., Sawtel P.A., Dunger D.B., et al. Can islet cell antibodies predict insulin-dependent diabetes in the general population?. Diabetes Care 1993, 16(1):45-50.
41. Palmer J.P., Asplin C.M., Clemons P., Lyen K., Tatpati O., Raghu P.K., et al. Insulin antibodies in insulin-dependent diabetes before insulin treatment. Science 1983, 222(4630):1337-1339.
42. Bingley P.J., Bonifacio R., Gale E.A.M. Can we really predict IDDM?. Diabetes 1993, 42(2):213-228.
43. Pipi E., Marketou M., Tsirogianni A. Distinct clinical and laboratory characteristics of latent autoimmune diabetes in adults in relation to type 1 and type 2 diabetes mellitus. World J Diabetes 2014, 5(4):505-510.
44. Kaufman D.L., Clare-Salzler M.C., Tian J., Forsthuber T., Ting G.S., Robinson P., et al. Spontaneous loss of T-cell tolerance of glutamine acid decarboxylase in murine insulin-dependent diabetes. Nature 1993, 366(6450):69-72.
45. Tisch R., Yang X.D., Singer S.M., Liblau R.S., Fugger L., McDevitt O. Immune response to glutamic acid decarboxylase toleranve correlates with insulinitis in non-obese diabetic mice. Nature 1993, 366(6450):72-75.
46. Leslie R.D., Atkinson M.A., Notkins A.L. Autoantigens IA-2 and GAD in type 1 (insulin-dependent) diabetes. Diabetologia 1999, 42:3-14.
47. Lowe R.M., Graham J., Sund G., Kockum I., Landin-Olsson M., Schaefer J.B., et al. The length of the CTLA-4 microsatellite (AT)N-repeat affects the risk for type 1 diabetes. Autoimmunity 2000, 32(3):173-180.
48. Ronkainen M.S., Savola K., Knip M. Antibodies to GAD65 epitopes at diagnosis and over the first 10years of clinical type 1 diabetes mellitus. Scand J Immunol Mar 2004, 59(3):334-340.
49. Borg H., Marcus C., Sjoblad S., Fernlund P., Sundkvist G. Islet cell antibody frequency differs from that of glutamic acid decarboxylase antibodies/IA2 antibodies after diagnosis of diabetes. Acta Paediatr 2000, 89(1):46-51.
50. Decochez K., Tits J., Coolens J.-L., Van Gaal L., Krzentowski G., Winnock F., et al. High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40years of age: the Belgian Diabetes Registry. Diabetes Care 2000, 23(6):838-844.
51. Han S., Donelan W., Wang H., Reeves W., Yang L.J. Novel autoantigens in type 1 diabetes. Am J Transl Res May 24 2013, 5(4):379-392.
52. Vermeulen I., Weets I., Costa O., Asanghanwa M., Verhaeghen K., Decochez K., et al. An important minority of prediabetic first-degree relatives of type 1 diabetic patients derives from seroconversion to persistent autoantibody positivity after 10years of age. Diabetologia Feb 2012, 55(2):413-420.
53. Barker J.M., Barriga K.J., Yu L., Miao D., Erlich H.A., Norris J.M., et al. Prediction of autoantibody positivity and progression to type 1 diabetes: diabetes autoimmunity study in the young (DAISY). J Clin Endocrinol Metab 2004, 89(8):3896-3902.
54. Truyen I., De Grijse J., Weets I., Kauffman L., Pipeleers L., Nanos N., et al. Identification of prediabetes in first-degree relatives at intermediate risk of type I diabetes. Clin Exp Immunol 2007, 149(2):243-250.
55. Savola K., Läärä E., Vähäsalo P., Kulmala P., Akerblom H.K., Knip M., et al. Dynamic pattern of disease-associated autoantibodies in siblings of children with type 1 diabetes. Diabetes 2001, 50(11):2625-2632.
56. Hummel M., Bonifacio E., Schmid S., Walter M., Knopff A., Ziegler A.G. Brief communication: early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents. Ann Intern Med Jun 1 2004, 140(11):882-886.
57. Krischer J.P., Cuthbertson D.D., Yu L., Orban T., Maclaren N., Jackson R., et al. Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes. J Clin Endocrinol Metab Jan 2003, 88(1):103-108.
58. Ziegler A.G., Rewers M., Simell O., Simell T., Lempainen J., Steck A., et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA Jun 19 2013, 309(23):2473-2479.
59. Ziegler A.G., Hummel M., Schenker M., Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 1999, 48:460-468.
60. Achenbach P., Bonifacio E., Koczwara K., Ziegler A. Natural history of type 1 diabetes. Diabetes 2005, 53(Suppl. 2):S25-S31.
61. Decochez K., De Leeuw I.H., Keymeulen B., Mathieu C., Rottiers R., Weets I., et al. IA-2 autoantibodies predict impending type I diabetes in siblings of patients. Diabetologia Dec 2002, 45(12):1658-1666.
62. Ota T., Takamura T., Nagai Y., Bando Y., Usuda R. Significance of IA-2 antibody in Japanese type 1 diabetes: its association with GAD antibody. Diabetes Res Clin Pract Jan 2005, 67(1):63-69.
63. Betterle C., Spadaccino A.C., Presotto F., Zanchetta R., Pedini B., Lai M., et al. The number of markers of pancreatic autoimmunity is proportional to the risk for type 1 diabetes mellitus in Italian and English patients with organ-specific autoimmune diseases. Ann N Y Acad Sci Apr 2002, 958:276-280.
64. Achenbach P., Warncke K., Reiter J., Naserke H.E., Williams A.J., Bingley P.J., et al. Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes Feb 2004, 53(2):384-392.
65. Mortensen H.B., Swift P.G., Holl R.W., Hougaard P., Hansen L., Bjoerndalen H., et al. Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12months after diagnosis. Pediatr Diabetes Jun 2010, 11(4):218-226.
66. Borg H., Gottsäter A., Fernlund P., Sundkvist G. A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes Jun 2002, 51(6):1754-1762.
67. Wenzlau J.M., Moua O., Sarkar S.A., Yu L., Rewers M., Eisenbarth G.S., et al. SlC30A8 is a major target of humoral autoimmunity in type 1 diabetes and a predictive marker in prediabetes. Ann NY Acad Sci 2008, 1150:256-259.
68. Schweiger M., Steffl M., Amselgruber W.M. The zinc transporter ZnT8 (slc30A8) is expressed exclusively in beta cells in porcine islets. Histochem Cell Biol Dec 2013, 140(6):677-684.
69. Wenzlau J.M., Juhl K., Yu L., Moua O., Sarkar S.A., Gottlieb P., et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 2007, 104(43):17040-17045.
70. Petruzelkova L., Ananieva-Jordanova R., Vcelakova J., Vesely Z., Stechova K., Lebl J., et al. The dynamic changes of zinc transporter 8 autoantibodies in Czech children from the onset of Type 1 diabetes mellitus. Diabet Med Feb 2014, 31(2):165-171.
71. Salonen K.M., Ryhänen S., Härkönen T., Ilonen J., Knip M., Finnish Pediatric Diabetes Register Autoantibodies against zinc transporter 8 are related to age, metabolic state and HLA DR genotype in children with newly diagnosed type 1 diabetes. Diabetes Metab Res Rev Nov 2013, 29(8):646-654.
72. Rogowicz-Frontczak A., Zozuliłska-Ziołkiewicz D., Litwinowicz M., Niedźwiecki P., Wyka K., Wierusz-Wysocka B. Are zinc transporter type 8 antibodies a marker of autoimmune thyroiditis in non-obese adults with new-onset diabetes?. Eur J Endocrinol Mar 14 2014, 170(4):651-658.
73. Kawasaki E. Type 1 diabetes and autoimmunity. Clin Pediatr Endocrinol 2014, 23(4):99-105.
74. Kaufman D.L., Erlander M.G., Clare-Salzler M., Atkinson M.A., Maclaren N.K., Tobin A.J. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992, 89(1):283-292.
75. Hoeldtke R.D., Bryner K.D., Hobbs G.R., Horvath G.G., Riggs J.E., Christie I., et al. Antibodies to glutamic acid decarboxylase and peripheral nerve function in type 1 diabetes. J Clin Endocrinol Metab 2000, 85(9):3297-3308.
76. Morano S., Tiberti C., Cristina G., Sensi M., Cipriani R., Guidobaldi L., et al. Autoimmune markers and neurological complications in non-insulin-dependent diabetes mellitus. Hum Immunol Sep 1999, 60(9):848-854.
77. Arikan E., Sabuncu T., Ozer E.M., Hatemi H. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus. J Diabetes Complications Sep-Oct 2005, 19(5):254-258.
78. Isomaa B., Almgren P., Henricsson M., Taskinen M.R., Tuomi I.T., Groop L., et al. Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA). Diabetes Care 1999, 22(8):1347-1353.
79. Myhill P., Davis W.A., Bruce D.G., Mackay I.R., Zimmet P., Davis T.M. Chronic complications and mortality in community-based patients with latent autoimmune diabetes in adults: the Fremantle Diabetes Study. Diabet Med Oct 2008, 25(10):1245-1250.
80. Mancardi M.M., Striano P., Giannattasio A., Baglietto M.G., Errichiello L., Zara F., et al. Type 1 diabetes and epilepsy: more than a casual association?. Epilepsia 2010, 51:320-321.
81. Saiz A., Blanco Y., Sabater L., Gonza'lez F., Bataller L., Casamitjana R., et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008, 131:2553-2563.
82. Olson J.A., Olson D.M., Sandborg C., Alexander S., Buckingham B. Type 1 diabetes mellitus and epilepsia partialis continua in a 6-year-old boy with elevated anti-GAD65 antibodies. Pediatrics 2002, 109(3):E50.
83. Falip M., Miró J., Carreño M., Jaraba S., Becerra J.L., Cayuela N., et al. Hypoglycemic seizures and epilepsy in type I diabetes mellitus. J Neurol Sci Nov 15 2014, 346(1-2):307-309.
84. Kwan P., Sills G.J., Kelly K., Butler E., Brodie M.J. Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study. Epilepsy Res 2000, 42(2-3):191-195.
85. McKnight K., Jiang Y., Hart Y., Cavey A., Wroe S., Blank M., et al. Serum antibodies in epilepsy and seizure-associated disorders. Neurology 2005, 65(11):1730-1736.
86. Errichiello L., Perruolo G., Pascarella A., Formisano P., Minetti C., Striano S., et al. Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: a study on 233 patients. J Neuroimmunol 2009, 211(1-2):120-123.
87. Wang C.P., Hsieh P.F., Chen C.C., Lin W.Y., Hu W.H., Yang D.Y., et al. Hyperglycemia with occipital seizures: images and visual evoked potentials. Epilepsia 2005, 46(7):1140-1144.
88. Cokar O., Aydin B., Ozer F. Non-ketotic hyperglycaemia presenting as epilepsia partialis continua. Seizure 2004, 13(4):264-269.
89. Manford M., Fuller G.N., Wade J.P. "Silent diabetes": non-ketotic hyperglycaemia presenting as aphasic status epilepticus. J Neurol Neurosurg Psychiatry 1995, 59(1):99-100.
90. Caraballo R.H., Sakr D., Mozzi M., Guerrero A., Adi J.N., Cersosimo R.O., et al. Symptomatic occipital lobe epilepsy following neonatal hypoglycaemia. Pediatr Neurol 2004, 31(1):24-29.
91. Walikonis J.E., Lennon V.A. Radioimmunoassay for glutamic acid decarboxylase [GAD65] autoantibodies as a diagnostic aid for stiffman syndrome and a correlate of susceptibility to type 1 diabetes mellitus. Mayo Clin Proc 1998, 73(12):1161-1166.
92. Dinkel K., Meinck H.M., Jury K.M., Karges W., Richter W. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann Neurol Aug 1998, 44(2):194-201.
93. McHugh J.C., Murray B., Renganathan R., Connolly S., Lynch T. GAD antibody positive paraneoplastic stiff person syndrome in a patient with renal cell carcinoma. Mov Disord 2007, 22(9):1343-1346.
94. Saiz A., Blanco Y., Sabater L., González F., Bataller L., Casamitjana R., et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008, 131(Pt 10):2553-2563.
95. Marine N., Boriana A. Olfactory markers of depression and Alzheimer's disease. Neurosci Biobehav Rev Sep 2014, 45:262-270.
96. Takeda A., Baba T., Kikuchi A., Hasegawa T., Sugeno N., Konno M., et al. Olfactory dysfunction and dementia in Parkinson's disease. J Parkinsons Dis 2014, 4(2):181-187.
97. Kivity S., Ortega-Hernandez O.D., Shoenfeld Y. Olfaction-a window to the mind. Isr Med Assoc J Apr 2009, 11(4):238-243.
98. Strous R.D., Shoenfeld Y. To smell the immune system: olfaction, autoimmunity and brain involvement. Autoimmun Rev Nov 2006, 6(1):54-60.
99. Bechter K. Updating the mild encephalitis hypothesis of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry Apr 5 2013, 42:71-91.
100. Katzav A., Ben-Ziv T., Blank M., Pick C.G., Shoenfeld Y., Chapman J. Antibody-specific behavioral effects: intracerebroventricular injection of antiphospholipid antibodies induces hyperactive behavior while anti-ribosomal-P antibodies induces depression and smell deficits in mice. J Neuroimmunol Jul 15 2014, 272(1-2):10-15.
101. Moscavitch S.D., Szyper-Kravitz M., Shoenfeld Y. Autoimmune pathology accounts for common manifestations in a wide range of neuro-psychiatric disorders: the olfactory and immune system interrelationship. Clin Immunol Mar 2009, 130(3):235-243.
102. Jahromi M.M. Haplotype specific alteration of diabetes MHC risk by olfactory receptor gene polymorphism. Autoimmun Rev Dec 2012, 12(2):270-274.
103. Neufeld M., Maclaren N., Blizzard R. Autoimmune polyglandular syndromes. Pediatr Ann 1980, 9(4):154-162.
104. Barker J.M. Clinical review: type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening. J Clin Endocrinol Metab 2006, 91:1210-1217.
105. Shaikh S.B., Haji I.M., Doddamani P., Rahman M. A study of autoimmune polyglandular syndrome (APS) in patients with type1 diabetes mellitus (T1DM) followed up at a teritiary care hospital. J Clin Diagn Res Feb 2014, 8(2):70-72.
106. Nagamine K., Peterson P., Scott H.S., Kudoh J., Minoshima S., Heino M., et al. Positional cloning of the APECED gene. Nat Genet 1997, 17(4):393-398.
107. Finnish-German APECED Consortium An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 1997, 17(4):399-403.
108. Betterle C., Lazzarotto F., Presotto F. Autoimmune polyglandular syndrome type 2: the tip of an iceberg?. Clin Exp Immunol 2004, 137(2):225-233.
109. Dosi R.V., Tandon N. A study on prevalence of thyroid auto-immunity in diabetes mellitus. J Indian Med Assoc 2010, 108(6):349-350.
110. Turkoglu Z., Kavala M., Kolcak O., Zindanci I., Can B. Autoimmune polyglandular syndrome-3C in a child. Dermatol Online J 2010, 16(3):8.
111. Rottembourg D., Deal C., Lambert M., Mallone R., Carel J.C., Lacroix A., et al. 21-Hydroxylase epitopes are targeted by CD8 T cells in autoimmune Addison's disease. J Autoimmun 2010, 35:309-315.
112. Pohjankoski H., Kautiainen H., Kotaniemi K., Korppi M., Savolainen A. Diabetes, coeliac disease, multiple sclerosis and chronic arthritis in first-degree relatives of patients with juvenile idiopathic arthritis. Acta Paediatr Jul 2012, 101(7):767-771.
113. Kahaly G.J. Polyglandular autoimmune syndromes. Eur J Endocrinol 2009, 161(1):11-20.
114. Flesch B.K., Matheis N., Alt T., Weinstock C., Bux J., Kahaly G.J. HLA class II haplotypes differentiate between the adult autoimmune polyglandular syndrome types II and III. J Clin Endocrinol Metab Jan 2014, 99(1):E177-E182.
115. Masood S., Sajid S., Jafferani A., Tabassum S., Ansar S. Multiple autoimmune syndromes associated with psoriasis: a rare clinical presentation. Oman Med J Mar 2014, 29(2):130-131.
116. Ramagopalan S.V., Dyment D.A., Valdar W., Herrera B.M., Criscuoli M., Yee I.M., et al. Autoimmune disease in families with multiple sclerosis: a population-based study. Lancet Neurol Jul 2007, 6(7):604-610.
117. Schneller C., Finkel L., Wise M., Hageman J.R., Littlejohn E. Autoimmune polyendocrine syndrome: a case-based review. Pediatr Ann 2013, 42:203-208.
118. Anaya J.M., Corena R., Castiblanco J., Rojas-Villarraga A., Shoenfeld Y. The kaleidoscope of autoimmunity: multiple autoimmune syndromes and familial autoimmunity. Expert Rev Clin Immunol 2007, 3:623-635.
119. Cardenas-Roldan J., Rojas-Villarraga A., Anaya J.M. How do autoimmune diseases cluster in families? A systematic review and meta-analysis. BMC Med 2013, 11:73-95.
120. Wagner A.M., Santana A., Hernndez M., Wiebe J.C., Novoa J., Mauricio D. Predictors of associated autoimmune diseases in families with type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium. Diabetes Metab Res Rev 2011, 27:493-498.
121. Hemminki K., Li X., Sundquist J., Sundquist K. Familial association between type 1 diabetes and other autoimmune and related diseases. Diabetologia 2009, 52:1820-1828.
122. Lebenthal Y., Yackobovitch-Gavan M., de Vries L., Phillip M., Lazar L. Coexistent autoimmunity in familial type 1 diabetes: increased susceptibility in sib-pairs?. Horm Res Paediatr 2011, 75:284-290.
123. Petaros P., Martelossi S., Tommasini A., Torre G., Caradonna M., Ventura A. Prevalence of autoimmune disorders in relatives of patients with celiac disease. Dig Dis Sci 2002, 47:1427-1431.
124. Deretzi G., Kountouras J., Koutlas E., Zavos C., Polyzos S., Rudolf J., et al. Familial prevalence of autoimmune disorders in multiple sclerosis in Northern Greece. Mult Scler 2010, 16:1091-1101.
125. Alonso A., Hernan M.A., Ascherio A. Allergy, family history of autoimmunediseases, and the risk of multiple sclerosis. Acta Neurol Scand 2008, 117:15-20.
126. Prina Cerai L.M., Weber G., Meschi F., Mora S., Bognetti E., Siragusa Y., et al. Prevalence of thyroid autoantibodies and thyroid autoimmune disease in diabetic children and adolescents. Diabetes Care 1994, 17(7):782-783.
127. Kordonouri O., Klinghammer A., Lang E.B., Gruters-Keslich A., Grabert M., Holl R.W. Thyroid autoimmunity in children and adolescents with type 1 diabetes. Diabetes Care 2002, 25(8):1346-1350.
128. Kabelitz M., Liesenkotter K.P., Stach B., Willgerodt H., Stablein W., Singendonk W., et al. The prevalence of anti-thyroid peroxidase antibodies and autoimmune thyroiditis in children and adolescents in an iodine replete area. Eur J Endocrinol 2003, 148(3):301-307.
129. Loviselli A., Velluzzi F., Mossa P., Cambosu M.A., Secci G., Atzeni F., et al. The Sardinian Autoimmunity Study: 3. Studies on circulating antithyroid antibodies in Sardinian schoolchildren: relationship to goiter prevalence and thyroid function. Thyroid 2001, 11(9):849-857.
130. Kaloumenou L., Duntas L., Alevizaki M., Mastorakos G., Mantzou E., Antoniou A., et al. Thyroid volume, prevalence of subclinical hypothyroidism and autoimmunity in children and adolescents. J Greek Paediatr Soc 2007, 70(5):107-114.
131. Holl R.W., Bohm B., Loos U., Grabert M., Heinze E., Homoki J. Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Horm Res 1999, 52(3):113-118.
132. Kakleas K., Paschali E., Kefalas N., Fotinou A., Kanariou M., Karayianni C., et al. Factors for thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Ups J Med Sci 2009, 114(4):214-220.
133. Vanderpump M.P., Tunbridge W.M., French J.M., Appleton D., Bates D., Clark F., et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995, 43(1):55-68.
134. Zamrazil V., Pohunkova D., Vavrejnova V., Nemec J., Vana S. Prevalence of thyroid diseases in two samples of Czech population. A preliminary study. Endocrinol Exp 1989, 23(2):97-104.
135. Doufas A.G., Mastorakos G., Chatziioannou S., Tseleni-Balafouta S., Piperingos G., Boukis M.A., et al. The predominant form of non-toxic goiter in Greece is now autoimmune thyroiditis. Eur J Endocrinol 1999, 140(6):505-511.
136. Shiau M.Y., Tsai S.T., Hwang J., Wu C.Y., Chang Y.H. Relationship between autoantibodies against glutamic acid decarboxylase, thyroglobulin/thyroid microsome and DNA topoisomerase II in the clinical manifestation of patients with type 1 diabetes mellitus in Taiwan. Eur J Endocrinol 2000, 142(6):577-585.
137. Maugendre D., Guilhem I., Karacatsanis C., Poirier J.Y., Leguerrier A.M., Lorcy Y., et al. Anti-TPO antibodies and screening of thyroid dysfunction in type 1 diabetic patients. Ann Endocrinol (Paris) 2000, 61(6):524-530.
138. Rattarasarn C., Diosdado M.A., Ortego J., Leelawattana R., Soonthornpun S., Setasuban W., et al. Thyroid autoantibodies in Thai type 1 diabetic patients: clinical significance and their relationship with glutamic acid decarboxylase antibodies. Diabetes Res Clin Pract 2000, 49(2-3):107-111.
139. Dayan C.M., Daniels G.H. Chronic autoimmune thyroiditis. N Engl J Med 1996, 335(2):99-107.
140. Blanchin S., Estienne V., Durand-Gorde J.M., Carayon P., Ruf J. Complement activation by direct C4 binding to thyroperoxidase in Hashimoto's thyroiditis. Endocrinology 2003, 144(12):5422-5429.
141. Bernet V. Autoimmune thyroid disease. Clinical immunology 1998, Mosby, London. R.R. Rich (Ed.).
142. Kordonouri O., Hartmann R., Deiss D., Wilms M., Gruters-Kieslich A. Natural course of autoimmune thyroiditis in type 1 diabetes: association with gender, age, diabetes duration, and puberty. Arch Dis Child Apr 2005, 90(4):411-414.
143. Triolo T.M., Armstrong T.K., McFann K., Yu L., Rewers M.G., Klingensmith G.J., et al. Additional autoimmune disease found in 33% of patients at type 1 diabetes onset. Diabetes Care 2011, 34(5):1211-1213.
144. Severinski S., Banac S., Severinski N.S., Ahel V., Cvijović K. Epidemiology and clinical characteristics of thyroid dysfunction in children and adolescents with type 1 diabetes. Coll Antropol Mar 2009, 33(1):273-279.
145. Barker J.M., Yu J., Yu L., Wang J., Miao D., Bao F., et al. Autoantibody 'subspecificity' in type 1 diabetes. Diabetes Care 2005, 28(4):850-855.
146. Sumnik Z., Drevinek P., Snajderova M., Kolouskova S., Sedlakova P., Pechova M., et al. HLA-DQ polymorphisms modify the risk of thyroid autoimmunity in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2003, 16(6):851-858.
147. De Block C.E., Silveira L.F.G., MacColl G.S., Bouloux P.M.G. The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity. J Endocrinol 2003, 176(3):293-304.
148. Landin-Olsson M., Karlsson A., Dahlquist G., Blom L., Lernmark A., Sundkvist G. Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children. Diabetologia 1989, 32(6):387-395.
149. Verge C.F., Howard N.J., Rowley M.J., Mackay I.R., Zimmet P.G., Egan M., et al. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study. Diabetologia 1994, 37(11):1113-1120.
150. Ahmed S.A., Talal N. Sex hormones and the immune system-part 2. Animal data. Baillieres Clin Rheumatol 1990, 4(1):13-31.
151. Fox H.S. Androgen treatment prevents diabetes in non-obese diabetic mice. J Exp Med 1992, 175(5):1409-1412.
152. Talal N. Autoimmunity and the immunological network. Arthritis Rheum 1978, 21:853.
153. Landin-Olsson M., Karlsson F.A., Lernmark A., Sundkvist G. Islet cell and thyrogastric antibodies in 633 consecutive 15- to 34-yr-old patients in the diabetes incidence study in Sweden. Diabetes 1992, 41(8):1022-1027.
154. Kokkonen J., Kiuttu J., Mustonen A., Rasanen O. Organ-specific antibodies in healthy and diabetic children and young adults. Acta Paediatr Scand 1982, 71(2):223-226.
155. Prazny M., Skrha J., Limanova Z., Vanickova Z., Hilgertova J., Prazna J., et al. Screening for associated autoimmunity in type 1 diabetes mellitus with respect to diabetes control. Physiol Res 2005, 54(1):41-48.
156. De Block C.E., de Leeuw I.H., Vertommen J.J., Rooman R.P., Du Caju M.V., Van Campehout C.M., et al. Beta-cell, thyroid, gastric, adrenal and coeliac autoimmunity and HLA-DQ types in type 1 diabetes. Clin Exp Immunol 2001, 126(2):236-241.
157. Talal N. Lessons from autoimmunity. Ann N Y Acad Sci Aug 12 1993, 690:19-23.
158. Hollowell J.G., Staehling N.W., Flanders W.D., Hannon W.H., Gunter E.W., Spencer C.A., et al. Serum TSH T4 and thyroid antibodies in the United States population 988 to 199: National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metabol 2002, 87(2):489-499.
159. Kim E.Y., Shin C.H., Yang S.W. Polymorphisms of HLA class II predispose children and adolescents with type 1 diabetes mellitus to autoimmune thyroid disease. Autoimmunity 2003, 36(3):177-181.
160. Kota S.K., Meher L.K., Jammula S., Kota S.K., Modi K.D. Clinical profile of coexisting conditions in type 1 diabetes mellitus patients. Diabetes Metab Syndr Apr-Jun 2012, 6(2):70-76.
161. Glastras S.J., Craig M.E., Verge C.F., Chan A.K., Cusumano J.M., Donaghue K.C. The role of autoimmunity at diagnosis of type 1 diabetes in the development of thyroid and celiac disease and microvascular complications. Diabetes Care 2005, 28(9):2170-2175.
162. Riley W.J., Maclaren N.K., Lezotte D.C., Spillar R.P., Rosenbloom A.L. Thyroid autoimmunity in insulin-dependent diabetes mellitus: the case for routine screening. J Pediatr Sep 1981, 99(3):350-354.
163. Czerniawska E., Szalecki M., Piatkowska E., Młynarski W., Bodalski J., Lewiński A. Prevalence of thyroid antibodies (TPO, and ATG) at the onset of type 1 diabetes mellitus in children treated in two diabetes centers in Lotz and Kielce. Med Wieku Rozwoj Apr-Jun 2003, 7(2):223-228.
164. Padberg S., Heller K., Usadel K.H., Schumm-Draeger P.M. One year prophylactic treatment of euthyroid Hashimoto's thyroiditis patients with levothyroxine: is there a benefit?. Thyroid 2001, 11(3):249-255.
165. Mohn A., Di Michele S., Di Luzio R., Tumini S., Chiarelli F. The effect of subclinical hypothyroidism on metabolic control in children and adolescents with type 1 diabetes mellitus. Diabet Med 2002, 19(1):70-73.
166. Chase H.P., Garg S.K., Cockerham R.S., Wilcox W.D., Walravens P.A. Thyroid hormone replacement and growth of children with subclinical hypothyroidism and diabetes. Diabet Med 1990, 7(4):299-303.
167. Hage M., Zantout M.S., Azar S.T. Thyroid disorders and diabetes mellitus. J Thyroid Res 2011, 10(4061):1-7.
168. Mouradian M., Abourizk N. Diabetes mellitus and thyroid disease. Diabetes Care 1983, 6(5):512-520.
169. Sinclair D. Analytical aspects of thyroid antibodies estimation. Autoimmunity 2008, 41(1):46-54.
170. Denzer C., Karges B., Näke A., Rosenbauer J., Schober E., Schwab K.O., et al. Subclinical hypothyroidism and dyslipidemia in children and adolescents with type 1 diabetes mellitus. Eur J Endocrinol Mar 15 2013, 168(4):601-608.
171. Kordonouri O., Hartmann R., Riebel T., Liesenkoetter K.P. Early treatment with l-thyroxine in children and adolescents with type 1 diabetes, positive thyroid antibodies, and thyroid gland enlargement. Pediatr Diabetes Aug 2007, 8(4):180-184.
172. Karges B., Muche R., Knerr I., Ertelt W., Wiesel T., Hub R., et al. Levothyroxine in euthyroid autoimmune thyroiditis and type 1 diabetes: a randomized, controlled trial. J Clin Endocrinol Metab May 2007, 92(5):1647-1652.
173. Umpierrez G.E., Latif K.A., Murphy M.B., Lambeth H.C., Stentz F., Bush A., et al. Thyroid dysfunction in patients with type 1 diabetes: a longitudinal study. Diabetes Care Apr 2003, 26(4):1181-1185.
174. Leong K.S., Wallymahmed M., Wilding J., MacFarlane I. Clinical presentation of thyroid dysfunction and Addison's disease in young adults with type 1 diabetes. Postgrad Med J Aug 1999, 75(886):467-470.
175. Chidakel A., Mentuccia D., Celi F.S. Peripheral metabolism of thyroid hormon and glucose homeostasis. Thyroid 2005, 15(8):899-903.
176. Mitrou P., Raptis S.A., Dimitriadis G. Insulin action in hyperthyroidism: a focus on muscle and adipose tissue. Endocr Rev 2010, 31(5):663-679.
177. Glinoer D., Cooper D.S. The propylthiouracil dilemma. Curr Opin Endocrinol Diabetes Obes Oct 2012, 19(5):402-407.
178. Karras S., Memi E., Kintiraki E., Krassas G.E. Pathogenesis of propylthiouracil-related hepatotoxicity in children: present concepts. J Pediatr Endocrinol Metab 2012, 25(7-8):623-630.
179. Kordonouri O., Maguire A.M., Knip M., Schober E., Lorini R., Holl R.W., et al. ISPAD clinical consensus guidelines2009 compendium. Other associated conditions in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes 2009, 10(Suppl. 12):204-210.
180. Standards of medical care in diabetes-2014. Diabetes Care 2014, 37(supplement 1):S14-S80.
181. Barker J.M. Clinical review: type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening. J Clin Endocrinol Metab Apr 2006, 91(4):1210-1217.
182. Carson H.J., Castelli M.J., Gattuso P. Incidence of neoplasia in Hashimoto's thyroiditis: a fine-needle aspiration study. Diagn Cytopathol Feb 1996, 14(1):38-42.
183. Scarpa V., Kousta E., Tertipi A., Vakaki M., Fotinou A., Petrou V., et al. Treatment with thyroxine reduces thyroid volume in euthyroid children and adolescents with chronic autoimmune thyroiditis. Horm Res Paediatr 2010, 73(1):61-67.
184. Karavanaki K., Kakleas K., Paschali E., Kefalas N., Konstantopoulos I., Petrou V., et al. Screening for associated autoimmunity in children and adolescents with type 1 diabetes mellitus (T1DM). Horm Res 2009, 71(4):201-206.
185. Karavanaki K., Karayianni C., Vassiliou I., Tzanela M., Sdogou T., Kakleas K., et al. Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review. J Pediatr Endocrinol Metab Sep 2014, 27(9-10):1011-1016.
186. Shi L., Li Y., Guan H., Li C., Shi L., Shan Z., et al. Usefulness of serum thyrotropin for risk prediction of differentiated thyroid cancers does not apply to microcarcinomas: results of 1,870 Chinese patients with thyroid nodules. Endocr J 2012, 59(11):973-980.
187. Pisello F., Geraci G., Lo Nigro C., Li Volsi F., Modica G., Sciumè C. Neck node dissection in thyroid cancer. A review G Chir Mar 2010, 31(3):112-118.
188. Malamut G., El Machhour R., Montcuquet N., Martin-Lannerée S., Dusanter-Fourt I., Verkarre V., et al. IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis. J Clin Invest Jun 2010, 120(6):2131-2143.
189. Guarino V., Castellone M.D., Avilla E., Melillo R.M. Thyroid cancer and inflammation. Mol Cell Endocrinol May 28 2010, 321(1):94-102.
190. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet Feb 17 2001, 357(9255):539-545.
191. Corrias A., Cassio A., Weber G., Mussa A., Wasniewska M., Rapa A., et al. Thyroid nodules and cancer in children and adolescents affected by autoimmune thyroiditis. Arch Pediatr Adolesc Med Jun 2008, 162(6):526-531.
192. Alonso N., Granada M.L., Salinas I., Lucas A.M., Reverter J.L., Junca J., et al. Serum pepsinogen I: an early marker of pernicious anemia in patients with type 1 diabetes. J Clin Endocrinol Metab 2005, 90(9):5254-5258.
193. Magzoub M.M., Abdel-Hameed A.A., Bottazzo G.F. Prevalence of islet cell and thyrogastric autoantibodies in Sudanese patients with type 1 diabetes. Diabet Med 1994, 11(2):188-192.
194. Bright G.M., Blizzard R.M., Kaiser D.L., Clarke W.L. Organ-specific autoantibodies in children with common endocrine diseases. J Pediatr 1982, 100(1):8-14.
195. Frohlich-Reiterer E.E., Huber J., Katz H., Suppan E., Obermayer-Pietsch B., Deutschmann A., et al. Do children and adolescents with type 1 diabetes mellitus have a higher frequency of parietal cell antibodies than healthy controls?. J PGN 2011, 52(5):558-562.
196. Kakleas K., Kostaki M., Critselis E., Karayianni C., Giannaki M., Anyfantakis K., et al. Gastric autoimmunity in children and adolescents with type 1 diabetes: a prospective study. Horm Res Paediatr 2012, 77(2):121-126.
197. De Block C.E., De Leeuw I.H., Van Gaal L.F., the Belgian Diabetes Registry High prevalence of manifestations of gastric autoimmunity in parietal cell antibody-positive type 1 diabetic patients. J Clin Endocrinol Metab 1999, 84(11):4062-4067.
198. Riley W.J., Toskes P.P., Maclaren N.K., Silverstein J.H. Predictive value of gastric parietal cell autoantibodies as a marker for gastric and hematologic abnormalities associated with insulin-dependent diabetes. Diabetes 1982, 31(12):1051-1055.
199. Ramachandran A., Rosenbloom A.L., Mohan V., Snehalatha C., Viswanathan M., Riley W.J., et al. Autoimmunity in South Indian patients with IDDM. Diabetes Care 1986, 9(4):435-436.
200. Gilon P., Tappaz M., Remade C. Localization of GAD-like immuno-reactivity in the pancreas and stomach of the rat and mouse. Histochemistry 1991, 96(4):355-365.
201. Toh B.H., van Driel I.R., Gleeson P.A. Pernicious anemia. New Engl JMed 1997, 337(20):1441-1448.
202. Tsai L.H., Taniyama K., Tanaka C. Gamma-aminobutyric acid stimulates acid secretion from the isolated guinea pig stomach. Am J Physiol 1987, 253(5 PT1):G601-G606.
203. Esteban M., Baxter A.G. Polyspecificity of autoimmune responses in type 1 (autoimmune) diabetes. Clin Exp Immunol 2001, 126(2):184-186.
204. De Block C.E., De Leeuw I.H., Van Gaal L.F. Autoimmune gastritis in type 1 diabetes: a clinically oriented review. Clin Endocrinol Metab Feb 2008, 93(2):363-371.
205. Hershko C., Ronson A., Souroujon M., Maschler I., Heyd J., Patz J. Variable hematologic presentation of autoimmune gastritis: age-related progression fromiron deficiency to cobalamin depletion. Blood 2006, 107(4):1673-1679.
206. Strober W., Neurath M.F. Immunologic diseases of the gastrointestinal tract. Clinical immunology 1998, 1408-1423. Mosby, London. R.R. Rich (Ed.).
207. Sibilla R., Santaguida M.G., Virili C., Gargano L., Nardo S., Della Guardia M., et al. Chronic unexplained anaemia in isolated autoimmune thyroid disease or associated with autoimmune related disorders. Clin Endocrinol 2008, 68(4):640-645.
208. Presotto F., Betterle C. Insulin-dependent diabetes mellitus: a constellation of autoimmune diseases. J Ped End Metab 1997, 10(5):455-469.
209. +-ATPase, the parietal cell antigen. Clin Exp Immunol 1987, 70(3):604-610.
210. De Block C.F., De Leeuw Ivo H., Pelckmans Paul A., Callens Dirk, Máday Emöke, Van Gaal Luc F. Delayed gastric emptying and gastric autoimmunity in type 1 diabetes. Diabetes Care May 2002, 25(5):912-917.
211. Kokkonen J. Parietal cell antibodies and gastric secretion in children with diabetes mellitus. Acta Paediatr Scand 1980, 69(4):485-489.
212. Hanukoglu A., Mizrachi A., Dalal I., Admoni O., Rakover Y., Bistritzer J., et al. Extrapancreatic autoimmune manifestations in type 1 diabetes patients and their first-degree relatives: a multicenter study. Diabetes Care 2003, 26(4):1235-1240.
213. Trudeau W.L., McGuigan J.E. Relations between serum gastrin levels and rates of gastric hydrochloric acid secretion. N Engl J Med 1971, 284(8):408-412.
214. Sipponen P., Valle J., Varis K., Kekki M., Ihamaki T., Siurala M. Fasting levels of serum gastrin in different functional and morphologic states of the antrofundal mucosa. An analysis of 860 subjects. Scand J Gastroenterol 1990, 25(5):513-519.
215. De Block C.E., de Leeuw I.H., Bogers J.J., Pelckmans P.A., Ieven M.M., Van Marck E.A., et al. Autoimmune gastropathy in type 1 diabetic patients with parietal cell antibodies: histological and clinical findings. Diabetes Care 2003, 26(1):82-88.
216. Neumann W.L., Coss E., Rugge M., Genta R.M. Autoimmune atrophic gastritispathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol 2013, 10(9):529-541.
217. Strickland R.G., Mackay I.R. A reappraisal of the nature and significance of chronic atrophic gastritis. Am J Dig Dis 1973, 18(5):426-440.
218. Telaranta-Keerie A., Kara R., Paloheimo L., Harkonen M., Sipponen P. Prevalence of undiagnosed advanced atrophic corpus gastritis in Finland: an observational study among 4256 volunteers without specific complaints. Scand J Gastroenterol 2010, 45(9):1036-1041.
219. +, K+-adenosine triphosphatase in human gastric autoimmunity. J Exp Med 2003, 198(8):1147-1156.
220. Veijola L.I., Oksanen A.M., Sipponen P.I., Rautelin H.I. Association of autoimmune type atrophic corpus gastritis with Helicobacter pylori infection. World J Gastroenterol 2010, 16(1):83-88.
221. Saito M., Morioka M., Wakasa K., Izumiyama K., Mori A., Irie T., et al. In Japanese patients with type a gastritis with pernicious anemia the condition is very poorly associated with Helicobacter pylori infection. J Infect Chemother 2013, 19(2):208-210.
222. Toh B.H. Diagnosis and classification of autoimmune gastritis. Autoimmun Rev April-May 2014, 13(4-5):459-462.
223. Carmel R. Reassessment of the relative prevalences of antibodies to gastric parietal cell and to intrinsic factor in patients with pernicious anaemia: influence of patient age and race. Clin Exp Immunol 1992, 89(1):74-77.
224. Alonso N., Granada M.L., Soldevila B., Salinas I., Joaquin C., Reverter J.L., et al. Serum autoimmune gastritis markers, pepsinogen i and parietal cell antibodies, in patients with type 1 diabetes mellitus: a 5-year prospective study. J Endocrinol Invest 2011, 34(5):340-344.
225. Tozzoli R., Kodermaz G., Perosa A.R., Tampoia M., Zucano A., Antico A., et al. Autoantibodies to parietal cells as predictors of atrophic body gastritis: a five-year prospective study in patients with autoimmune thyroid diseases. Autoimmun Rev 2010, 10(2):80-83.
226. Solcia E., Fiocca R., Villani L., Gianatti A., Cornaggia M., Chiaravalli A., et al. Morphology and pathogenesis of endocrine hyperplasias, precarcinoid lesions, and carcinoids arising in chronic atrophic gastritis. Scand J Gastroenterol Suppl 1991, 180:146-159.
227. Muhsen K., Barak M., Henig C., Alpert G., Ornoy A., Cohen D. Is the association between Helicobacter pylori infection and anemia age dependent?. Helicobacter Oct 2010, 15(5):467-472.
228. Korstanje A., van Eeden S., Offerhaus J.A., Waltman F.L., Hartog G., Roelandse F.W., et al. Comparison between serology and histology in the diagnosis of advanced gastric body atrophy: a study in a Dutch primary community. J Clin Gastroenterol 2008, 42(1):18-22.
229. Checchi S., Montanaro A., Pasqui L., Ciuoli C., Cevenini G., Sestini F., et al. Serum ghrelin as a marker of atrophic body gastritis in patients with parietal cell antibodies. J Clin Endocrinol Metab 2007, 92(11):4346-4351.
230. De Block C.E., De Leeuw I.H., Decochez K., Winnock F., Van Autreve J., Van Campenhout C.M., et al. The presence of thyrogastric antibodies in first degree relatives of type 1 diabetic patients is associated with age and proband antibody status. J Clin Endocrinol Metab Sep 2001, 86(9):4358-4363.
231. Centanni M., Marignani M., Gargano L., Corleto V.D., Casini A., Delle Fave G., et al. Atrophic body gastritis in patients with autoimmune thyroid disease. Arch Intern Med 1999, 159(15):1726-1730.
232. De Block C.E., De Leeuw I.H., Rooman R.P., Winnock F., Du Caju M.V., Van Gaal L.F. Gastric parietal cell antibodies are associated with glutamic acid decarboxylase-65 antibodies and the HLA DQA1*0501-DQB1*0301 haplotype in Type 1 diabetes mellitus. Belgian Diabetes Registry. Diabet Med Aug 2000, 17(8):618-622.
233. Becker K.G. Comparative genetics of type 1 diabetes and autoimmune disease: common loci, common pathways?. Diabetes Jul 1999, 48(7):1353-1358.
234. Silveira P.A., Baxter A.G., Cain W.E., van Driel I.R. A major linkage region on distal chromosome 4 confers susceptibility to mouse autoimmune gastritis. J Immunol May 1 1999, 162(9):5106-5111.
235. Maclaren N.K., Riley W.J. Thyroid, gastric, and adrenal autoimmunities associated with insulin-dependent diabetes mellitus. Diabetes Care Sep-Oct 1985, 8(Suppl. 1):34-38.
236. Kawasaki E., Takino H., Yano M., Uotani S., Matsumoto K., Takao Y., et al. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 1994, 43(1):80-86.
237. Martino G.V., Tappaz M.L., Braghi S., Dozio N., Canal N., Pozza G., et al. Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immuno-trapping enzyme activity assay: relation to insulin-dependent diabetes mellitus. J Autoimmunity 1991, 4(6):915-923.
238. Yokota I., Matsuda J., Naito E., Ito M., Shima K., Kuroda Y. Comparison of GAD and ICA512/IA-2 antibodies at and after onset of IDDM. Diabetes Care 1998, 21(1):49-52.
239. Ahrén B. GABA inhibits thyroid hormone secretion in the mouse. Thyroidology Dec 1989, 1(3):105-108.
240. Sterzl I., Hrdá P., Matucha P., Cerovská J., Zamrazil V. Anti-Helicobacter pylori, anti-thyroid peroxidase, anti-thyroglobulin and anti-gastric parietal cells antibodies in Czech population. Physiol Res 2008, 57(Suppl. 1):S135-S141.
241. Newton K.P., Singer S.A. Celiac disease in children and adolescents: special considerations. Semin Immunopathol Jul 2012, 34(4):479-496.
242. Holmes G.K. Coeliac disease and type 1 diabetes mellitus-the case for screening. Diabet Med 2001, 18(3):169-177.
243. Hansen D., Brock-Jacobsen B., Lund E., Bjorn C., Hansen L.P., Nielsen C., et al. Clinical benefit of a gluten-free diet in type 1 diabetic children with screening-detected celiac disease: a population-based screening study with 2years' follow-up. Diabetes Care 2006, 29(11):2452-2456.
244. Liu E., Li M., Bao F., Miao D., Rewers M.J., Eisenbarth G.S., et al. Need for quantitative assessment of transglutaminase autoantibodies for celiac disease in screening-identified children. J Pediatr 2005, 146(4):494-499.
245. Salardi S., Volta U., Zucchini S., Fiorini E., Maltoni G., Vaira B., et al. Prevalence of celiac disease in children with type 1 diabetes mellitus increased in the mid-1990s: an 18-year longitudinal study based on anti-endomysial antibodies. J Pediatr Gastroenterol Nutr 2008, 46(5):612-614.
246. Acerini C.L., Ahmed M.L., Ross K.M., Sullivan P.B., Bird G., Dunger D.B. Coeliac disease in children and adolescents with IDDM: clinical characteristics and response to gluten-free diet. Diabet Med Jan 1998, 15(1):38-44.
247. Sumnik Z., Kolouskova S., Malcova H., Vavrinec J., Venhacova J., Lebl J., et al. High prevalence of coeliac disease in siblings of children with type 1 diabetes. Eur J Pediatr Jan 2005, 164(1):9-12.
248. Murray J.A. Celiac disease in patients with an affected member, type 1 diabetes, iron-deficiency, or osteoporosis?. Gastroenterology Apr 2005, 128(4 Suppl. 1):S52-S56.
249. Faas S., Schork N.J. Genetic analysis of NIDDM. The study of quantitatiretraits. Diabetes 1996, 45(1):1-14.
250. Sumnik Z., Kolouskova S., Cinek O., Kotalova S., Vavrinec J., Snajderova M. HLA-DQA1*05-DQB1*0201 positivity predisposes to coeliac disease in Czech diabetic children. Acta Paediatr 2000, 89(12):1426-1430.
251. Arato A., Korner A., Veres G., Dezsofi A., Ujpal I., Madacsy L. Frequency of coeliac disease in Hungarian children with type 1 diabetes mellitus. Eur J Pediatr 2003, 162(1):1-5.
252. Martin-Villa J.M., Lopez-Suarez J.C., Perez-Blas M., Martinez-Laso J., Ferre-Lopez S., Garcia-Torre C., et al. Coeliac- and enteropathy-associated autoantibodies in Spanish insulin-dependent diabetes mellitus patients and their relation to HLA antigens. J Diabetes Complications 2001, 15:38-43.
253. Ascher H. Coeliac disease and type 1 diabetes: an affair still with much hidden behind the veil. Acta Paediatr 2001, 90(11):1217-1225.
254. Ludvigsson J.F., Ludvigsson J., Ekbom A., Montgomery S.M. Celiac disease and risk of subsequent type 1 diabetes: a general population cohort study of children and adolescents. Diabetes Care 2006, 29(11):2483-2488.
255. Larsson K., Carlsson A., Cederwall E., Jonsson B., Neiderud J., Jonsson B., et al. Annual screening detects coeliac disease in children with type 1 diabetes. Pediatr Diabetes 2008, 9(4 Pt 2):354-359.
256. Peretti N., Bienvenu F., Bouvet C., Fabien N., Tixier F., Thivolet C., et al. The temporal relationship between the onset of type 1 diabetes and coeliac disease: a study based on immunoglobulin A antitransglutaminase screening. Pediatrics 2004, 113(5):418-422.
257. Not T., Tomasini A., Torini G., Buratti E., Pocecco M., Tortul C., et al. Undiagnosed coeliac disease and risk of autoimmune disorders in subjects with type 1 diabetes mellitus. Diabetologia 2001, 44(2):151-155.
258. Pocecco M., Ventura A. Coeliac disease and insulin-dependent diabetes mellitus: a causal association?. Acta Paediatr 1995, 84(12):1432-1433.
259. Lorini R., Scaramuzza A., Vitali L., d'Annunzio G., Avanzini M.A., De Giacomo C., et al. Clinical aspects of coeliac in children with insulin dependent diabetes mellitus. J Pediatr Endocrinol Metab 1996, 9(Suppl. 1):101-111.
260. Hummel M., Bonifacio E., Stern M., Dittler J., Schimmel A., Ziegler A.G. Development of coeliac disease-associated antibodies in offspring of parents with type 1 diabetes. Diabetologia 2000, 43(8):1005-1011.
261. MacFarlane A.J., Burghardt K.M., Kelly J., Simell T., Simell O., Altosaar I., et al. A type 1 diabetes-related protein from wheat (Triticum aestivum). cDNA clone of a wheat storage globulin, Gib1, linked to islet damage. J Biol Chem 2003, 278(1):54-63.
262. Toscano V., Conti F.G., Anastasi E., Mariani P., Tiberti C., Poggi M., et al. Importance of gluten in the induction of endocrine autoantibodies and organ disfunction in adolescent coeliac patients. Am J Gastroenterol 2000, 95(7):1742-1748.
263. Barera G., Bonfati R., Viscardi M., Bazzigaluppi E., Calori G., Meschi F., et al. Occurence of coeliac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study. Pediatrics 2002, 109(5):833-838.
264. Lie B.A., Sollid L.M., Ascher H., Ek J., Akselsen H.E., Ronningen K.S., et al. A gene telomeric of the HLA class I region is involved in predisposition to both type 1 diabetes and coeliac disease. Tissue Antigens 1999, 54:162-168.
265. Bratanic N., Schweiger D.S., Mendez A., Bratina N., Battelino T., Vidan-Jeras B. An influence of HLA-A, B, DR, DQ, and MICA on the occurrence of celiac disease in patients with type 1 diabetes. Tissue Antigens 2010, 76:208-215.
266. Funda D.P., Kaas A., Bock T., Tlaskalova-Hogenova H., Buschard K. Gluten-free diet prevents diabetes in NOD mice. Diabetes Metab Res Rev 1999, 15:323-327.
267. Wang G.-S., Gruber H., Smyth P., Puilido O., Rosenberg L., Duguid W., et al. Hydrolysed casein diet protects BB rats from developing diabetes by promoting islet neogenesis. J Autoimmun 2000, 15:407-416.
268. Graham S., Courtois P., Malaisse W.J., Rozing J., Scott F.W., AMcI Mowat Enteropathy precedes type 1 diabetes in the BB rat. Gut 2004, 53:1437-1444.
269. Flohe S.B., Wasmuth H.E., Kerad J.B., Beales P.E., Pozzilli P., Elliott R.B., et al. A wheat based, diabetes promoting diet induces a Th-1 type cytokine bias in the gut of NOD mice. Cytokine 2003, 21:149-154.
270. Ott P.A., Herzog B.A., Quast S., Hofsetter H., Boehm B.O., Tary-Lehmann M. Islet-cell antigen reactive T cells show different expansion rates and Th1/Th2 differentiation in type 1 diabetic patients and healthy controls. Clin Immunol 2005, 115:102-114.
271. Ziegler A.-G., Schmid S., Huber D., Hummel M., Bonifacio E. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 2003, 290:1721-1728.
272. Prescott S.L., Smith P., Tang M., Palmer D.J., Sinn J., Huntley S.J., et al. The importance of early complementary feeding in the development of oral tolerance: concerns and controversies. Pediatr Allergy Immunol 2008, 19:375-380.
273. Bosi E., Molteni L., Radaelli M.G., Folini L., Fermo I., Bazzigaluppi E., et al. Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia 2006, 49:2824-2827.
274. Kuitunen M., Saukkonen T., Ilonen J., Akerblom H.K., Savilahti E. Intestinal permeability to mannitol and lactulose in children with type 1 diabetes with the HLADQB1* 02 allele. Autoimmunity 2002, 35:365-368.
275. Secondulfo M., Iafusco D., Carratu R., deMagistris L., Sapone A., Generoso M., et al. Ultrastructural mucosal alterations and increased intestinal permeability in nonceliac, type 1 diabetic patients. Dig Liver Dis 2004, 36:35-45.
276. Savilahti E., Ormala T., Saukkonen T., Sandini-Pohjavuori U., Kantele J.M., Arato A., et al. Jejuna of patients with insulin-dependent diabetes mellitus (IDDM) show signs of immune activation. Clin Exp Immunol 1999, 116:70-77.
277. Westerholm-Ormio M., Vaarala O., Pihkala P., Ilonen J., Savilahti E. Immunologic activity in the small intestinal mucosa of pediatric patients with type 1 diabetes. Diabetes 2003, 52:2287-2295.
278. Klemetti P., Savilahti E., Ilonen J., Akerblom H.K., Vaarala O. T-cell reactivity to wheat gluten in patients with insulin-dependent diabetes mellitus. Scand J Immunol 1998, 47:48-53.
279. Mojibian M., Chakir H., Lefebvre D.E., Crookshank J.A., Sonier B., Keeley E., et al. Diabetes-specific HLA-DR restricted proinflammatory T cell response to wheat polypeptides in tissue transglutaminase antibody-negative patients with type 1 diabetes. Diabetes 2009, 58:1789-1796.
280. Helgason T., Jonasson M.R. Evidence for a food additive as a cause of ketosis-prone diabetes. Lancet 1981, 316:716-720.
281. Helgason T., Ewen S.W.B., Ross I.S., Stowers J.M. Diabetes produced in mice by smoked/cured mutton. Lancet 1982, 320:1017-1022.
282. Virtanen S.M., Laara E., Hypponen E., Reijonen H., Rasanen L., Aro A., et al. Cow's milk consumption, HLA-DQB1 genotype, and type 1 diabetes: a nested case-control study of siblings of children with diabetes. Childhood diabetes in Finland study group. Diabetes 2000, 49:912-917.
283. Littorin B., Blom P., Scholin A., Arnqvist H.J., Blohme G., Bolinder J., et al. Lower levels of plasma 25-hydroxyvitamin D among adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 2006, 49:2847-2852.
284. Cooke A. Review series on helminths, immune modulation and the hygiene hypothesis: how might infection modulate the onset of type 1 diabetes?. Immunology 2008, 126:12-17.
285. Borchers A.T., Uibo R., Gershwin M.E. The geoepidemiology of type 1 diabetes. Autoimmun Rev 2010, 9:A355-A365.
286. Shapira Y., Agmon-Levin N., Shoenfeld Y. Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 2010, 34:J168-J177.
287. Carlsson A.K., Axelsson I.E., Borulf S.K., Bredberg A.C., Lindberg B.A., Sjoberg K.G., et al. Prevalence of IgA-antiendomysium and IgA-antigliadin autoantibodies at diagnosis of insulin-dependent diabetes mellitus in Swedish children and adolescents. Pediatrics 1999, 103(6 Pt1):1248-1252.
288. Doolan A., Donaghue K., Fairchild J., Wong M., Williams A.J. Use of HLA typing in diagnosing coeliac disease in patients with type 1 diabetes. Diabetes Care 2005, 28(4):806-809.
289. de Graaff L.C., Smit J.W., Radder J.K. Prevalence and clinical significance of organ-specific autoantibodies in type 1 diabetes mellitus. Neth J Med Jul-Aug 2007, 65(7):235-247.
290. Mansour A.A., Najeeb A.A. Coeliac disease in Iraqi type 1 diabetic patients. Arab J Gastroenterol Jun 2011, 12(2):103-105.
291. Kanungo A., Shtauvere-Brameus A., Samal K.C., Sanjeevi C.B. Autoantibodies to tissue transglutaminase in patients from eastern India with malnutrition-modulated diabetes mellitus, insulin-dependent diabetes mellitus, and non-insulin-dependent diabetes mellitus. Ann N Y Acad Sci 2002, 958:232-234.
292. Bao F., Yu L., Babu S., Wang T., Hoffenberg E.J., Rewers M., et al. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J Autoimmun 1999, 13(1):143-148.
293. Reddick B.K., Crowell K., Fu B. Clinical inquiries: what blood tests help diagnose celiac disease?. J Fam Pract Dec 2006, 55(12):1088. [1090, 1093].
294. Contreas G., Valletta E., Ulmi D., Cantoni S., Pinelli L. Screening of coeliac disease in north Italian children with type 1 diabetes: limited usefulness of HLA-DQ typing. Acta Paediatr May 2004, 93(5):628-632.
295. Chan K.N., Philips A.D., Mirakian R., Walter-Smith J.A. Endomysial antibody screening in children. J Pediatr Gastroenterol Nutr 1994, 18(3):316-320.
296. Spiekerkoetter U., Seissler J., Wendel U. General screening for celiac disease is advisable in children with type 1 diabetes. Horm Metab Res Apr 2002, 34(4):192-195.
297. Hopper A.D., Cross S.S., Hurlstone D.P., McAlindon M.E., Lobo A.J., Hadjivassiliou M., et al. Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool. BMJ 2007, 334(7596):729.
298. Abrams J.A., Diamond B., Rotterdam H., Green P.H. Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy. Dig Dis Sci 2004, 49(4):546-550.
299. Misak Z., Hojsak I., Jadresin O., Kekez A.J., Abdovic S., Kolacek S. Diagnosis of coeliac disease in children younger than 2years. J Pediatr Gastroenterol Nutr 2013, 56(2):201-205.
300. Villalta D., Crovatto M., Stella S., Tonutti E., Tozzoli R., Bizzaro N. False positive reactions for IgA and IgG anti-tissue transglutaminase antibodies in liver cirrhosis are common and method-dependent. Clin Chim Acta 2005, 356(1-2):102-109.
301. Ludvigsson J.F., Neovius M., Hammarström L. Association between IgA deficiency & other autoimmune conditions: a population-based matched cohort study. J Clin Immunol May 2014, 34(4):444-451.
302. Wang N., Truedsson L., Elvin K., Andersson B.A., Rönnelid J., Mincheva-Nilsson L., et al. Serological assessment for celiac disease in IgA deficient adults. PLoS One Apr 7 2014, 9(4):e93180.
303. Husby S., Koletzko S., Korponay-Szabo I.R., Mearin M.L., Phillips A., Shamir R., et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012, 54(1):136-160.
304. Kakleas K., Karayianni C., Critselis E., Papathanasiou A., Petrou V., Fotinou A., et al. The prevalence and risk factors for coeliac disease among children and adolescents with type 1 diabetes mellitus. Diabetes Res Clin Pract Nov 2010, 90(2):202-208.
305. Kordonouri O., Dieterich W., Schuppan D., Weber G., Muller C., Sarioglu N., et al. Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent coeliac disease in patients with type 1 diabetes mellitus. Diabetes UK Diabet Med 2002, 17(6):441-444.
306. Sategna-Guidetti C., Grosso S., Pulitano R., Benaduce E., Dani F., Carta Q. Coeliac disease and insulin-dependent diabetes mellitus. Screening in an adult population. Dig Dis Sci 1994, 39(8):1633-1637.
307. Sakly W., Bienvenu F., Peretti N., Lachaux A., Morel S., Bouvier R., et al. IgA anti-transglutaminase antibodies as a tool for screening atypical forms of coeliac disease in a French at-risk paediatric population. Eur J Gastroenterol Hepatol 2005, 17(2):235-239.
308. Buysschaert M., Tomasi J.P., Hermans M.P. Prospective screening for biopsy proven coeliac disease, autoimmunity and malabsorption markers in Belgian subjects with Type 1 diabetes. Diabet Med 2005, 22(7):889-892.
309. Cerruti F., Bruno G., Chiarelli F., Lorini R., Meschi F., Sacchetti C. Younger age at onset and sex predict coeliac disease in children and adolescents with type 1 diabetes. Diabetes Care 2004, 27(6):1294-1298.
310. Shahbazkhani B., Faezi T., Akbari M.R., Mohamadnejad M., Sotoudeh M., Rajab A., et al. Coeliac disease in Iranian type I diabetic patients. Dig Liver Dis 2004, 36(3):191-194.
311. Schober E., Bittmann B., Granditsch G., et al. Screening by anti-endomysium antibody for coeliac disease in diabetic children and adolescents in Austria. Pediatr Gastroenterol Nutr 2000, 30(4):391-396.
312. Freemark M., Levitsky L.L. Screening for celiac disease in children with type 1 diabetes: two views of the controversy. Diabetes Care Jun 2003, 26(6):1932-1939.
313. Rubio-Tapia A., Kyle R.A., Kaplan E.L., Johnson D.R., Page W., Erdtmann F., et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 2009, 137(1):88-93.
314. Saukkonen T., Vaisanen S., Akerblom H.K., Savilahti E., Childhood Diabetes in Finland Study Group Coeliac disease in children and adolescents with type 1 diabetes: a study of growth, glycaemic control, and experiences of families. Acta Paediatr 2002, 91(3):297-302.
315. Scaramuzza A.E., Mantegazza C., Bosetti A., Zuccotti G.V. Type 1 diabetes and celiac disease: the effects of gluten free diet on metabolic control. World J Diabetes Aug 15 2013, 4(4):130-134.
316. Errichiello S., Esposito O., Di Mase R., Camarca M.E., Natale C., Limongelli M.G., et al. Celiac disease: predictors of compliance with a gluten-free diet in adolescents and young adults. J Pediatr Gastroenterol Nutr 2010, 50(1):54-60.
317. Berrington de Gonzalez A., Hartge P., Cerhan J.R., Flint A.J., Hannan L., MacInnis R.J., et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med 2010, 363(23):2211-2219.
318. Nóvoa Medina Y., López-Capapé M., Lara Orejas E., Alonso Blanco M., Camarero Salces C., Barrio Castellanos R. Impact of diagnosis of celiac disease on metabolic control of type 1 diabetes. An Pediatr (Barc) 2008, 68(1):13-17.
319. Saadah O.I., Zacharin M., O'Callaghan A., Oliver M.R., Catto-Smith A.G. Effect of gluten-free diet and adherence on growth and diabetic control in diabetics with coeliac disease. Arch Dis Child 2004, 89(9):871-876.
320. Kaukinen K., Salmi J., Lahtela J., Siljamäki-Ojansuu U., Koivisto A.M., Oksa H., et al. No effect of gluten-free diet on the metabolic control of type 1 diabetes in patients with diabetes and celiac disease. Retrospective and controlled prospective survey. Diabetes Care 1999, 22(10):1747-1748.
321. Hill I.D., Dirks M.H., Liptak G.S., Colletti R.B., Fasano A., Guandalini S., et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005, 40(1):1-19.
322. NIH consensus development conference on celiac disease. NIH Consens State Sci Statements 2004, 21(1):1-23.
323. Grant R.W., Kirkman M.S. Trends in the evidence level for the American Diabetes Association's "Standards of Medical Care in Diabetes" from 2005 to 2014. Diabetes Care 2015, 38(1):6-8.
324. Husby S., Koletzko S., Korponay-Szabo I.R., Mearin M.L., Phillips A., Shamir R., et al. ESPGHAN Working Group on Coeliac Disease Diagnosis, ESPGHAN Gastroenterology Committee, European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatric Gastroenterol Nutr 2012, 54:136-160.
325. Nevoral J., Kotalova R., Hradsky O., Valtrova V., Zarubova K., Lastovicka J., et al. Symptom positivity is essential for omitting biopsy in children with suspected celiac disease according to the new ESPGHAN guidelines. Eur J Pediatr Nov 2013, 15.
326. Sumnik Z., Cinek O., Bratanic N., Lebl J., Rozsai B., Limbert C., et al. Thyroid autoimmunity in children with coexisting type 1 diabetes mellitus and coeliac disease: a multicentre study. J Pediatr Endocrinol Metabol 2006, 19(4):517-522.
327. Li Voon Chong J.S., Leong K.S., Wallymahmed M., Sturgess R., MacFarlane I.A. Is coeliac disease more prevalent in young adults with coexisting type 1 diabetes mellitus and autoimmune thyroid disease compared with those with type 1 diabetes mellitus alone?. Diabet Med 2002, 19(4):334-337.
328. Kaukinen K., Collin P., Mykkanen A.H., Partanen J., Maki M., Salmi J. Coeliac disease and autoimmune endocrinologic disorders. Dig Dis Sci 1999, 44(7):1428-1443.
329. Kaspers S., Kordonouri O., Schober E., Grabert M., Hauffa B.P., Holl R.W. Anthropometry, metabolic control and thyroid autoimmunity in type 1 diabetes with celiac disease: a multicenter study. J Pediatr 2004, 145(6):790-795.
330. Wiebolt J., Achterbergh R., den Boer A., van der Leij S., Marsch E., Suelmann B., et al. Clustering of additional autoimmunity behaves differently in Hashimoto's patients compared with Graves' patients. Eur J Endocrinol May 2011, 164(5):789-794.
331. Berti I., Trevisiol C., Tommasini A., Citta A., Neri E., Geatti O., et al. Usefulness of screening program for celiac disease in autoimmune thyroiditis. Dig Dis Sci 2000, 45(2):403-406.
332. Hadithi M., Meijer J.W., Willekens F., Kerckhaert J.A., Heijmans R., Pena A.S., et al. Coeliac disease in Dutch patients with Hashimoto's thyroiditis and vice versa. Wo r l d Journal of Gastroenterology 2007, 13(11):1715-1722.
333. Chong C.L., Biswas M., Benton A., Jones M.K., Kingham J.G. Prospective screening for coeliac disease in patients with Graves' hyperthyroidism using anti-gliadin and tissue transglutaminase antibodies. Clin Endocrinol (Oxf) 2005, 62(3):303-306.
334. Sari S., Yesilkaya E., Egritas O., Bideci A., Dalgic B. Prevalence of celiac disease in Turkish children with autoimmune thyroiditis. Dig Dis Sci 2009, 54(4):830-832.
335. Larizza D., Calcaterra V., De Giacomo C., De Silvestri A., Asti M., Badulli C., et al. Celiac disease in children with autoimmune thyroid disease. J Pediatr 2001, 139(5):738-740.
336. Meloni A., Mandas C., Jores R.D., Congia M. Prevalence of autoimmune thyroiditis in children with celiac disease and effect of gluten withdrawal. J Pediatr 2009, 155(1):51-55.
337. Oderda G., Rapa A., Zavallone A., Strigini L., Bona G. Thyroid autoimmunity in childhood celiac disease. J Pediatr Gastroenterol Nutr 2002, 35(5):704-705.
338. Marwaha R.K., Garg M.K., Tandon N., Kanwar R., Narang A., Sastry A., et al. Glutamic acid decarboxylase (anti-GAD) & tissue transglutaminase (anti-TTG) antibodies in patients with thyroid autoimmunity. Indian J Med Res Jan 2013, 137(1):82-86.
339. van der Pals M., Ivarsson A., Norström F., Högberg L., Svensson J., Carlsson A. Prevalence of thyroid autoimmunity in children with celiac disease compared to healthy 12-year olds. Autoimmune Dis 2014, 2014:417356.
340. Ide A., Eisenbarth G.S. Genetic susceptibility in type 1 diabetes and its associated autoimmune disorders. Rev Endocrinol Metab Dis 2003, 4(3):243-253.
341. Von Herrath M.G., Fujinami R.S., Witton J.L. Microorganisms and autoimmunity: making the barren field fertile?. Nat Rev Microbiol 2003, 1(2):151-157.
342. Ventura A., Neri E., Ughi C., Leopaldi A., Città A., Not T. Gluten-dependent diabetes-related and thyroid-related autoantibodies in patients with celiac disease. J Pediatr 2000, 137(2):263-265.
343. Farloni A., Laureti S., Santeusanio F. Autoantibodies in autoimmune polyendocrine syndrome type II. Endocrin Metab Clin North Am 2002, 31(2):369-389.
344. Eisenbarth G.S., Gottlieb P.A. Autoimmune polyendocrine syndromes. N Engl J Med 2004, 350(20):2068-2079.
345. Kirmizibekmez H., Yesiltepe Mutlu R.G., Demirkiran Urganci N., Oner A. Autoimmune polyglandular syndrome type 2: a rare condition in childhood. J Clin Res Pediatr Endocrinol 2015, 7(1):80-82.
346. Leong K.S., Wallymahmed M., Wilding J., MacFarlane I. Clinical presentation of thyroid dysfunction and Addison's disease in young adults with type 1 diabetes. Postgrad Med J 1999, 75(886):467-470.
347. Armstrong L., Bell P.M. Lesson of the Week: Addison's disease presenting as reduced insulin requirement in insulin dependent diabetes. BMJ 1996, 312(7046):1601-1602.
348. Falorni A., Laureti S., Nikoshkov A., Picchio M.L., Hallengren B., Vandewalle C.N., et al. 21-Hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Belgian Diabetes Registry. Clin Exp Immunol 1997, 107(2):341-346.
349. Peterson P., Salmi H., Hyoty H., Miettinen A., Ilonen J., Reijonen H., et al. Steroid 21-hydroxylase autoantibodies in insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group. Clin Immunol Immunopathol 1997, 82(1):37-42.
350. Fichna M., Fichna P., Gryczyńska M., Walkowiak J., Zurawek M., Sowiński J. Screening for associated autoimmune disorders in Polish patients with Addison's disease. Endocrine Apr 2010, 37(2):349-360.
351. Brewer K.W., Parziale V.S. Eisenbarth GS Screening patients with insulin-dependent diabetes mellitus for adrenal insufficiency. N Engl J Med 1997, 337(3):202.
352. Marks S.D., Girgis R., Couch R. Screening for adrenal antibodies in children with type 1 diabetes and autoimmune thyroid disease. Diabetes Care 2003, 26(11):3187-3188.
353. Yu L., Brewer K.W., Gates S., Wu A., Wang T., Babu S.R., et al. Eisenbarth.DRB1-04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease. J Clin Endocrinol Metabol 1999, 84(1):328-335. [Vol.].
354. Myhre A.G., Undlien D.E., Lovas K., Uhlving S., Nedrebo B.G., Kristian J.F., et al. Autoimmune adrenocortical failure in Norway: autoantibodies and HLA class II associations related to clinical features. J Clin Endocrinol Metab 2002, 87(2):618-623.
355. Barker J.M., Ide A., Hostetler C., Yu L., Miao D., Fain P.R., et al. Endocrine and immunogenetic testing in individuals with type 1 diabetes and 21-hydroxylase autoantibodies: Addison's disease in a high risk population. J Clin Endocrinol Metab 2005, 90(1):128-134.
356. McAulay V., Frier B.M. Addison's disease in type 1 diabetes presenting with recurrent hypoglycaemia. Postgrad Med J 2000, 76(894):230-232.
357. Pearce S., Leech N. Toward precise forecasting of autoimmune endocrinopathy. J Clin Endocrinol Metabol 2004, 89(2):544-547.
358. Jaeger C., Hatziagelaki E., Petzoldt R., Bretzel R.G. Comparative analysis of organ-specific autoantibodies and coeliac disease-associated antibodies in type 1 diabetic patients, their first-degree relatives, and healthy control subjects. Diabetes Care 2001, 24(1):27-32.
359. de Graaff L.C., Martín-Martorell P., Baan J., Ballieux B., Smit J.W., Radder J.K. Long-term follow-up of organ-specific antibodies and related organ dysfunction in type 1 diabetes mellitus. Neth J Med Feb 2011, 69(2):66-71.
360. Neufeld M., Maclaren N.K., Riley W.J., Lezotte D., McLoughlin J.V., Silverstein J., et al. Islet cell and other organ-specific antibodies in U.S. Caucasians and Blacks with insulin-dependent diabetes mellitus. Diabetes 1980, 29(8):589-592.
361. Betterle C., Zanette F., Pedini B., Pressoto F., Rapp L.B., Monciotti C.M., et al. Clinical and subclinical organ-specific autoimmune manifestations in type 1 (insulin-dependent) diabetic patients and their first-degree relatives. Diabetologia 1984, 26(6):431-436.
362. Betterle C., Scalici C., Presotto F., Pedini B., Moro L., Rigon F., et al. The natural history of adrenal function in autoimmune patients with adrenal autoantibodies. J Endocrinol 1988, 117(3):467-475.
363. Betterle C., Coco G., Zanchetta R. Adrenal cortex autoantibodies in subjects with normal adrenal function. Best Pract Res Clin Endocrinol Metab 2005, 19(1):85-99.
364. Auburger G., Gispert S., Lahut S., Omür O., Damrath E., Heck M., et al. 12q24 locus association with type 1 diabetes: SH2B3 or ATXN2?. World J Diabetes Jun 15 2014, 5(3):316-327.
365. Taïeb A., Picardo M. Clinical practice. Vitiligo. N Engl J Med Jan 8 2009, 360(2):160-169.
366. Montagnani A., Tosti A., Patrizi A., Salardi S., Cacciari E. Diabetes mellitus and skin diseases in childhood. Dermatologica 1985, 170(2):65-68.
367. Kemp E.H., Waterman E.A., Weetman A.P. Autoimmune aspects of vitiligo. Autoimmunity 2001, 34(1):65-77.
368. Bahceci M., Tuzcu A., Pasa S., Ayyildiz O., Tuzcu S. Polyglandular autoimmune syndrome type III accompanied by common variable immunodeficiency. Cynecol Endocrinol 2004, 19(1):47-50.
369. Pohjankoski H., Kautiainen H., Korppi M., Savolainen A. Simultaneous juvenile idiopathic arthritis and diabetes mellitus type 1 - a Finnish nationwide study. J Rheumatol Feb 2012, 39(2):377-381. See comment in PubMed Commons below, [See comment in PubMed Commons below].
370. Nagy K.H., Lukacs K., Sipos P., Hermann R., Madacsy L., Soltesz G. Type 1 diabetes associated with Hashimoto's thyroiditis and juvenile rheumatoid arthritis: a case report with clinical and genetic investigations. Pediatr Diabetes Dec 2010, 11(8):579-582.
371. Nolfi-Donegan D., Viswanathan A., Chefitz D., Moorthy L. Case report of a child with recently diagnosed diabetes mellitus type 1 and subsequent systemic arthritis. Internet J Pediatr Neonatol 2012, 14(1). [serial on the internet, cited 2015 May 25, Available from: https://ispub.com/ijpn/14/1/14117].
372. Tack C.J., Kleijwegt F.S., Van Riel P.L., Roep B.O. Development of type 1 diabetes in a patient treated with anti-TNF-alpha therapy for active rheumatoid arthritis. Diabetologia 2009, 52(7):1442-1444.
373. Versini M., Jeandel P.Y., Rosenthal E., Shoenfeld Y. Obesity in autoimmune diseases: not a passive bystander. Autoimmun Rev Sep 2014, 13(9):981-1000.
374. Verbeeten K.C., Elks C.E., Daneman D., Ong K.K. Association between childhood obesity and subsequent Type 1 diabetes: a systematic review and meta-analysis. Diabet Med Jan 2011, 28(1):10-18.
375. Pang T.T., Chimen M., Goble E., Dixon N., Benbow A., Eldershaw S.E., et al. Inhibition of islet immunoreactivity by adiponectin is attenuated in human type 1 diabetes. J Clin Endocrinol Metab Mar 2013, 98(3):E418-E428.
376. Procaccini C., Pucino V., Mantzoros C.S., Matarese G. Leptin in autoimmune diseases. Metabolism Jan 2015, 64(1):92-104.
377. Symmons D.P., Bankhead C.R., Harrison B.J., Brennan P., Barrett E.M., Scott D.G., et al. Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. Arthritis Rheum Nov 1997, 40(11):1955-1961.
378. Feldt-Rasmussen U. Thyroid and leptin. Thyroid May 2007, 17(5):413-419.
379. Kumar S., Han J., Li T., Qureshi A.A. Obesity, waist circumference, weight change and the risk of psoriasis in US women. J Eur Acad Dermatol Venereol Oct 2013, 27(10):1293-1298.
380. Love T.J., Zhu Y., Zhang Y., Wall-Burns L., Ogdie A., Gelfand J.M., et al. Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis Aug 2012, 71(8):1273-1277.
381. Araujo J., Brandao L.A., Guimarães R.L., Santos S., Falcão E.A., Milanese M., et al. Prevalance of autoimmune thyroid dysfunction in young Brazillian patients with type 1 diabetes. Pediatr Diabetes 2008, 9(4pt1):272-276.